Optical lens maker LightPath beats Q1 revenue estimates

Reuters
2025/11/12
Optical lens maker LightPath beats Q1 revenue estimates

Overview

  • LightPath fiscal Q1 2026 revenue grows 79% yr/yr, beating analysts' expectations

  • Company reports fiscal Q1 net loss of $2.9 mln, widening from prior year, as operating expenses rose

  • Secured $18.2 mln and $22.1 mln IR camera orders for delivery in CY 2026-2027

Outlook

  • LightPath expects sustainable revenue growth through fiscal 2026 and beyond

  • Company anticipates increased demand due to geopolitical uncertainties and defense spending

  • LightPath aims to scale deliveries against its $90 mln order backlog

Result Drivers

  • PURCHASE ORDERS - $4.8 mln order for IR camera systems for public safety applications and $18.2 mln order from global tech customer drove revenue growth

  • BLACKDIAMOND GLASS - Shift from Germanium optics to proprietary BlackDiamond™ glass expands adoption in defense markets

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$15.06 mln

$12.66 mln (4 Analysts)

Q1 EPS

-$0.07

Q1 Net Income

-$2.89 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the office equipment peer group is "buy"

  • Wall Street's median 12-month price target for LightPath Technologies Inc is $8.50, about 8.5% above its November 10 closing price of $7.78

Press Release: ID:nPn9mzJZBa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10